133 results on '"Tachi, Yoshihiko"'
Search Results
2. B-mode ultrasonographic diagnosis in gallbladder wall thickening
3. Benefit From Nonsurgical Treatment for Asymptomatic Pancreatolithiasis
4. A Predictive Strategy for Nonsurgical Management of Pancreatic Stones.
5. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease
6. Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan
7. Diagnostic performance of real-time tissue elastography in chronic hepatitis C patients with sustained virological response
8. Large or multiple pseudocysts can impede or complicate the nonsurgical treatment of pancreatolithiasis
9. Large Inflammatory Myofibroblastic Tumor of the Esophagus: A Case Report and Literature Review
10. Pancreatolithiasis with an anatomic variant of Wirsung duct: a case report
11. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy
12. Nonsurgical treatment for asymptomatic pancreatolithiasis is meaning: A case report
13. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response
14. Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response
15. Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon‐free therapy in hepatitis C virus genotype 1b
16. Impact of HBV Infection on Outcomes of Direct-Acting Antiviral Therapy of Chronic Hepatitis C
17. Pancreatic Stones
18. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response
19. Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response
20. Pancreatic Stones: Clinical Outcomes With Nonsurgical Treatment in a Japanese Single-Center Study.
21. Prevalence of Hepatitis C Virus Genotype 1A in Japan and Correlation of Mutations in the NS5A Region and Single-Nucleotide Polymorphism of Interleukin-28B With the Response to Combination Therapy With Pegylated-Interferon-Alpha 2B and Ribavirin
22. B-mode ultrasonographic diagnosis in gallbladder wall thickening
23. Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan
24. Pancreatolithiasis with an anatomic variant of Wirsung duct: a case report.
25. Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection
26. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C
27. Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct‐acting antivirals
28. Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan
29. Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan
30. The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study
31. Impact of HBV Infection on Outcomes of Direct-Acting Antiviral Therapy of Chronic Hepatitis C
32. Mo1396 - Liver Stiffness Reduction Correlates with Histological Characteristics of Hepatitis C Patients with Sustained Virological Response
33. Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease
34. Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon-free therapy in hepatitis C virus genotype 1b
35. Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
36. Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response
37. Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B
38. Liver Fibrosis Indices for Identifying Patients at Low Risk of Developing Hepatocellular Carcinoma after Eradication of HCV
39. Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan
40. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.
41. Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis
42. Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus
43. Tu1045 Effect of α-Fetoprotein Levels After Interferon Therapy on Regression of Liver Fibrosis in Chronic Hepatitis C Patient Who Achieved an SVR
44. Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response
45. Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan.
46. 941 The Correlation Between SNP of IL28B and Mutations in the ISDR of NS5A of HCV 1A, 1b, 2A, 2B, 3a and the Response to Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy
47. Sa1055 IL28B Polymorphism is Associated With Liver Steatosis and Treatment Response to PEG-Interferon Plus Ribavirin Combination Therapy, but is Not Associated With Hepatocarcinogenesis in Patients With Chronic Hepatitis C
48. Liver Fibrosis Indices for Identifying Patients at Low Risk of Developing Hepatocellular Carcinoma after Eradication of HCV
49. Large or multiple pseudocysts can impede or complicate the nonsurgical treatment of pancreatolithiasis.
50. Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.